ESR1 and breast carcinoma: Here, we investigate the role of miRNAs in regulating gene expression in breast cancer cell lines we developed previously, which express wildtype (WT) ER or heterozygously express either the Y537S or the D538G mutation, the two most common ER LBD mutations, from the endogenous ER locus (16).